HAVAS Ebitda from 2010 to 2026

HAVAS Stock   15.56  0.05  0.32%   
HAVAS SA's EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 424.6 M. From 2010 to 2026 HAVAS SA EBITDA quarterly data regression line had arithmetic mean of  360,638,235 and r-squared of  0.55. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
477.2 M
Current Value
424.6 M
Quarterly Volatility
45.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check HAVAS SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HAVAS SA's main balance sheet or income statement drivers, such as Depreciation And Amortization of 88.6 M, Interest Expense of 11.2 M or Total Revenue of 3 B, as well as many indicators such as Price To Sales Ratio of 0.72, Dividend Yield of 0.14 or PTB Ratio of 1.05. HAVAS financial statements analysis is a perfect complement when working with HAVAS SA Valuation or Volatility modules.
  
This module can also supplement various HAVAS SA Technical models . Check out the analysis of HAVAS SA Correlation against competitors.
Analyzing HAVAS SA's Ebitda over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Ebitda has evolved provides context for assessing HAVAS SA's current valuation and future prospects.

Latest HAVAS SA's Ebitda Growth Pattern

Below is the plot of the Ebitda of HAVAS SA over the last few years. It is HAVAS SA's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HAVAS SA's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

HAVAS Ebitda Regression Statistics

Arithmetic Mean360,638,235
Geometric Mean358,228,729
Coefficient Of Variation12.54
Mean Deviation36,195,156
Median335,000,000
Standard Deviation45,238,809
Sample Variance2046.5T
Range142.2M
R-Value0.74
Mean Square Error971.8T
R-Squared0.55
Significance0.0006
Slope6,672,917
Total Sum of Squares32744.8T

HAVAS Ebitda History

2026424.6 M
2025477.2 M
2024415 M
2023369 M
2022425 M

About HAVAS SA Financial Statements

HAVAS SA stakeholders use historical fundamental indicators, such as HAVAS SA's Ebitda, to determine how well the company is positioned to perform in the future. Although HAVAS SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in HAVAS SA's assets and liabilities are reflected in the revenues and expenses on HAVAS SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HAVAS SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA477.2 M424.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in HAVAS Stock

HAVAS SA financial ratios help investors to determine whether HAVAS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVAS with respect to the benefits of owning HAVAS SA security.